From: Mucormycosis in renal transplant recipients: review of 174 reported cases
Feature | All patients | Proportion of patients who died |
---|---|---|
Mean age, y | 45.9 (range 11–70) | |
Gender | ||
Male | 133(76%) | 58/133 (43.6%) |
Female | 41(24%) | 16/41 (39.0%) |
Underlying conditions | ||
No | 30/174 (25.1%) | 15/30 (50.0%) |
Diabetes | 75/174 (43.1%) | 25/75 (33.3%) |
Other conditionsa | 19/174 (3.4%) | 7/19 (36.8%) |
Not reported | 50/174 (28.7%) | 27/50 (54.0%) |
Transplanted organs | ||
Kidney alone | 162/174(93.1%) | 71/162(43.8%) |
Kidney combined with other organs | 12/174(6.9%) | 9/12(75.0%) |
Anti-allograft rejection therapy | ||
Yes | 33/174(18.97%) | 12/33(36.4%) |
No | 16/174(9.1%) | 7/16(43.8%) |
Not reported | 125/174(71.8%) | 55/125(44.0%) |
Induction therapy | ||
Yes | 33/174(19.0%) | 12/33(36.4%) |
No | 16/174(9.2%) | 7/16(43.8%) |
Not reported | 125/174(71.8%) | 55/125(71.8%) |
Reduce immunosuppressive drugs | ||
Yes | 98(56.3%) | 38/98(38.8%) |
No | 6(3.4%) | 2/6(33.3%) |
Not reported | 70(40.2%) | 34/70(48.6%) |
Diagnostic methods | ||
Histopathology only | 72/174(41.4%) | 33/72(45.8%) |
Culture only | 25/174(14.4%) | 9/25(36.0%) |
Histopathology and culture | 77/174(44.3%) | 32/77(41.6%) |